Biotage AB (publ) releases its 2008 Annual Report
4/8/2009 2:30 AM EST
Biotage is today releasing its 2008 annual report.
The company generated net sales of 385,3 MSEK (397,6 MSEK).
The operating result amounted to 22,5 MSEK (16,7 MSEK) and total profit after tax for the year of 299,1 MSEK (99,4 MSEK).
Total profit per share of 3,38 SEK (1,12 SEK).
Financial Goals 2009 and onwards
Biotage business is under changes after the divestment of the Biosystems business and the ongoing restructuring of the remaining Discovery Chemistry business. The decision to close down the factory in Charlottesville, Virigina, and to outsource the manufacturing of Biotage’s instrument, results in relatively big organizational and operational changes. By reason hereof new more specific financial goals will be set during the latter part of 2009, when the effects from the ongoing changes may be measured more in detail. Short term Biotage will adjust the organization to the new conditions and will re-establish organic growth in the business. At the same time Biotage will profit from its strong financial position and seek to acquire attractive businesses or products.
The full report is available at:
http://www.biotage.com/Graphics/20385.pdfContact:
Torben Jörgensen, President and CEO
Tel: +46 707 49 05 84,